Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Tax Provisions: 2020-2023

Historic Tax Provisions for Prime Medicine (PRME) over the last 4 years, with Dec 2023 value amounting to -$279,000.

  • Prime Medicine's Tax Provisions fell 532.26% to -$134,000 in Q2 2024 from the same period last year, while for Jun 2024 it was -$77,000, marking a year-over-year increase of 46.90%. This contributed to the annual value of -$279,000 for FY2023, which is 70.57% up from last year.
  • Prime Medicine's Tax Provisions amounted to -$279,000 in FY2023, which was up 70.57% from -$948,000 recorded in FY2022.
  • In the past 5 years, Prime Medicine's Tax Provisions ranged from a high of $1.9 million in FY2020 and a low of -$948,000 during FY2022.
  • Over the past 3 years, Prime Medicine's median Tax Provisions value was -$500,000 (recorded in 2021), while the average stood at -$575,667.
  • As far as peak fluctuations go, Prime Medicine's Tax Provisions crashed by 126.32% in 2021, and later soared by 70.57% in 2023.
  • Yearly analysis of 4 years shows Prime Medicine's Tax Provisions stood at $1.9 million in 2020, then crashed by 126.32% to -$500,000 in 2021, then slumped by 89.60% to -$948,000 in 2022, then spiked by 70.57% to -$279,000 in 2023.